New therapy shows promise in treating advanced leukemia
Washington, Nov 6 (ANI): Scientists from Fred Hutchinson Cancer Research Centre have come up with a novel treatment that would improve survival rates of leukemia and pre-leukemia patients.
They used a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients,
The study showed that patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome – a pre-leukemic condition – experienced a remission with the help of combination of low-intensity chemotherapy, targeted radiation delivery by an antibody and a stem-cell transplant.
The findings revealed that forty percent of the patients were alive a year after treatment and approximately 35 percent had survived three years, about the same rates as patients who received similar treatment but whose disease was already in remission and who had much more favourable risk for relapse when therapy began.
According to Dr John Pagel, a transplant oncologist and assistant member of the Hutchinson Center’s Clinical Research Division, patients over the age of 50 with active, advanced leukemia and myelodysplastic syndrome pose the most difficult treatment challenges because standard transplant therapy rarely works.
“The results appear to be very encouraging and warrant us to study it further for patients who really have no significant other curative options,” he added.
The results of the research appear online in the journal Blood. (ANI)
Related Posts
Two units of umbilical cord blood ‘reduce leukemia recurrence risk’
Washington, Nov 14 (ANI): If patients with acute leukaemia are transplanted with two units of umbilical cord blood (UCB), their risk of the disease recurrence is significantly reduced, according to a new study from the Masonic Cancer Center, University... |
New therapeutic target for leukaemia identified
Scientists from The University of Texas M. D. Anderson Cancer Centre and The University of Texas Medical School at Houston have identified a potential new therapeutic target for leukaemia.
They have found that apart from glucose, leukemia... |
New gene findings may help treat infant leukemia
Washington, Dec 6 (ANI): Researchers from the Children's Hospital of Philadelphia, in collaboration with the Children's Oncology Group, have identified specific genes, dubbed partner genes, which fuse with another gene to drive an often-fatal... |
Radiation therapy ‘treats pain in patients with advanced cancer’
Washington, Nov 4 (ANI): Scientists from University of Pittsburgh Cancer Institute (UPCI) have pioneered a radiation therapy procedure that could help reduce pain in patients with cancer that has spread to the spine.
Lead researcher Dr Dwight E. Heron,... |
Novel treatment gives hope to lymphoma, leukemia patients
Researchers have offered a new hope for a new therapy for patients with certain types of lymphoma and leukemia.
PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Piper Cancer Center in collaboration with... |
Key cause of chronic leukemia progression identified
Scientists in the US have discovered why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis.
They found that chronic myeloid leukemia (CML) progresses when immature white blood cells... |
